These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18541994)

  • 1. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function.
    Perry JR; Frayling TM
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):371-7. PubMed ID: 18541994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.
    Dimas AS; Lagou V; Barker A; Knowles JW; Mägi R; Hivert MF; Benazzo A; Rybin D; Jackson AU; Stringham HM; Song C; Fischer-Rosinsky A; Boesgaard TW; Grarup N; Abbasi FA; Assimes TL; Hao K; Yang X; Lecoeur C; Barroso I; Bonnycastle LL; Böttcher Y; Bumpstead S; Chines PS; Erdos MR; Graessler J; Kovacs P; Morken MA; Narisu N; Payne F; Stancakova A; Swift AJ; Tönjes A; Bornstein SR; Cauchi S; Froguel P; Meyre D; Schwarz PE; Häring HU; Smith U; Boehnke M; Bergman RN; Collins FS; Mohlke KL; Tuomilehto J; Quertemous T; Lind L; Hansen T; Pedersen O; Walker M; Pfeiffer AF; Spranger J; Stumvoll M; Meigs JB; Wareham NJ; Kuusisto J; Laakso M; Langenberg C; Dupuis J; Watanabe RM; Florez JC; Ingelsson E; McCarthy MI; Prokopenko I;
    Diabetes; 2014 Jun; 63(6):2158-71. PubMed ID: 24296717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.
    Pascoe L; Tura A; Patel SK; Ibrahim IM; Ferrannini E; Zeggini E; Weedon MN; Mari A; Hattersley AT; McCarthy MI; Frayling TM; Walker M; ;
    Diabetes; 2007 Dec; 56(12):3101-4. PubMed ID: 17804762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes.
    Rosengren AH; Braun M; Mahdi T; Andersson SA; Travers ME; Shigeto M; Zhang E; Almgren P; Ladenvall C; Axelsson AS; Edlund A; Pedersen MG; Jonsson A; Ramracheya R; Tang Y; Walker JN; Barrett A; Johnson PR; Lyssenko V; McCarthy MI; Groop L; Salehi A; Gloyn AL; Renström E; Rorsman P; Eliasson L
    Diabetes; 2012 Jul; 61(7):1726-33. PubMed ID: 22492527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic origins of low birth weight.
    Yaghootkar H; Freathy RM
    Curr Opin Clin Nutr Metab Care; 2012 May; 15(3):258-64. PubMed ID: 22406741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits.
    De Silva NM; Frayling TM
    Curr Opin Lipidol; 2010 Feb; 21(1):44-50. PubMed ID: 19956073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity.
    Haupt A; Guthoff M; Schäfer SA; Kirchhoff K; Machicao F; Gallwitz B; Staiger H; Stefan N; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2009 May; 94(5):1775-80. PubMed ID: 19258404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study for type 2 diabetes: clinical applications.
    Lyssenko V; Groop L
    Curr Opin Lipidol; 2009 Apr; 20(2):87-91. PubMed ID: 19276887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes risk alleles near BCAR1 and in ANK1 associate with decreased β-cell function whereas risk alleles near ANKRD55 and GRB14 associate with decreased insulin sensitivity in the Danish Inter99 cohort.
    Harder MN; Ribel-Madsen R; Justesen JM; Sparsø T; Andersson EA; Grarup N; Jørgensen T; Linneberg A; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E801-6. PubMed ID: 23457408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of type 2 diabetes risk loci on insulin requirements in type 1 diabetes.
    Moosavi M; Séguin J; Li Q; Polychronakos C
    Horm Res Paediatr; 2012; 77(5):305-8. PubMed ID: 22584884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perspectives on the contribution of genetics to the pathogenesis of type 2 diabetes mellitus].
    Brunetti A; Chiefari E; Foti D
    Recenti Prog Med; 2011 Dec; 102(12):468-75. PubMed ID: 22258190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms.
    Schäfer SA; Machicao F; Fritsche A; Häring HU; Kantartzis K
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S9-24. PubMed ID: 21864758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
    ; Saxena R; Voight BF; Lyssenko V; Burtt NP; de Bakker PI; Chen H; Roix JJ; Kathiresan S; Hirschhorn JN; Daly MJ; Hughes TE; Groop L; Altshuler D; Almgren P; Florez JC; Meyer J; Ardlie K; Bengtsson Boström K; Isomaa B; Lettre G; Lindblad U; Lyon HN; Melander O; Newton-Cheh C; Nilsson P; Orho-Melander M; Råstam L; Speliotes EK; Taskinen MR; Tuomi T; Guiducci C; Berglund A; Carlson J; Gianniny L; Hackett R; Hall L; Holmkvist J; Laurila E; Sjögren M; Sterner M; Surti A; Svensson M; Svensson M; Tewhey R; Blumenstiel B; Parkin M; Defelice M; Barry R; Brodeur W; Camarata J; Chia N; Fava M; Gibbons J; Handsaker B; Healy C; Nguyen K; Gates C; Sougnez C; Gage D; Nizzari M; Gabriel SB; Chirn GW; Ma Q; Parikh H; Richardson D; Ricke D; Purcell S
    Science; 2007 Jun; 316(5829):1331-6. PubMed ID: 17463246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comeback for the beta cells in the pathogenesis of diabetes].
    Mulder H
    Lakartidningen; 2010 Nov 10-16; 107(45):2796-800. PubMed ID: 21179864
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical risk factors, DNA variants, and the development of type 2 diabetes.
    Lyssenko V; Jonsson A; Almgren P; Pulizzi N; Isomaa B; Tuomi T; Berglund G; Altshuler D; Nilsson P; Groop L
    N Engl J Med; 2008 Nov; 359(21):2220-32. PubMed ID: 19020324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea.
    Kang ES; Kim MS; Kim CH; Nam CM; Han SJ; Hur KY; Ahn CW; Cha BS; Kim SI; Lee HC; Kim YS
    Transplantation; 2009 Sep; 88(5):693-8. PubMed ID: 19741467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?
    Florez JC
    Diabetologia; 2008 Jul; 51(7):1100-10. PubMed ID: 18504548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes.
    Müssig K; Staiger H; Machicao F; Stancáková A; Kuusisto J; Laakso M; Thamer C; Machann J; Schick F; Claussen CD; Stefan N; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1353-60. PubMed ID: 19141580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating new candidate genes for neonatal diabetes: functional and genetic studies of insulin secretion in type 2 diabetes.
    Rutter GA
    Endocr Dev; 2007; 12():75-85. PubMed ID: 17923771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update.
    Lyssenko V
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):385-92. PubMed ID: 18541996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.